EPSRC Hub for Quantitative Modelling in Healthcare
Lead Research Organisation:
UNIVERSITY OF EXETER
Department Name: Mathematics
Abstract
Our Hub brings together a team of mathematicians, statisticians and clinicians with a range of industrial partners, patients and other stakeholders to focus on the development of new quantitative methods for applications to diagnosing and managing long-term health conditions such as diabetes and psychosis and combating antimicrobial infections such as sepsis and bronchiectasis. This approach is underpinned by the world-leading expertise in diabetes, microbial communities, medical mycology and mental health concentrated at the University of Exeter. It uses the breadth of theoretical and methodological expertise of the Hub's team to give innovative approaches to both research and translational aspects.
Although quantitative modelling is a well-established tool used in the fields of economics and finance, cutting-edge quantitative analysis has only recently become possible in health care. However, up to now it has been restricted to health economics in the context of healthcare services and systems management. Applications to develop future therapies, optimising treatments and improving community health and care are in its infancy. This is due to a number of challenges from both mathematical (methodological) as well as clinical and patients' perspectives. Our Hub approach will allow us to develop novel statistical and mathematical methodologies of relevance to our clinical and industrial partners, informed by relevant patient groups. Building this new generation of quantitative models requires that we advance our mathematical understanding of the effective network interaction and emergent patterns of health and disease. Clinical translation of mathematical and statistical advances necessitates that we further develop robust uncertainty quantification methodology for novel therapy, treatment or intervention prediction and evaluation.
NHS long-term planning aspires to deliver healthcare that is more personalised and patient centred, more focused on prevention, and more likely to be delivered in the community, out of hospital. Our Hub will contribute to this through developing mathematical and statistical tools needed to inform clinical decision making on a patient-by-patient basis. The basis of this approach is quantitative patient-specific mathematical models, the parameters of which are determined directly from individual patient's data.
As an example of this, our recent research in the field of mental health has revealed that movement signatures could be used to distinguish between healthy subjects and patients with schizophrenia. This hypothesis was tested in a cohort of people with schizophrenia and we developed a quantitative analysis pipe line allowing for classification of individuals as healthy or patients. The features used for classification involving data-driven models of individual movement properties as well as measures of coordination with a virtual partner were proposed as a novel biomarker of social phobias. To validate this in an NHS setting, we have recently carried out a feasibility study in collaboration with the early intervention for psychosis teams in Devon Partnership Mental Health Trust. The success of this study could significantly advance the early detection of psychosis by enabling diagnosis using novel markers that are easily measured and analysed and improve accuracy of diagnosis.
Indeed, personalised quantitative models hold the promise for transforming prognosis, diagnosis and treatment of a wide range of clinical conditions. For example, in diabetes where a range of treatment options exist, identifying the optimal medication, and the pattern of its delivery, based upon the profile of the individual will enable us to maximise efficacy, whilst minimising unwanted side effects.
Although quantitative modelling is a well-established tool used in the fields of economics and finance, cutting-edge quantitative analysis has only recently become possible in health care. However, up to now it has been restricted to health economics in the context of healthcare services and systems management. Applications to develop future therapies, optimising treatments and improving community health and care are in its infancy. This is due to a number of challenges from both mathematical (methodological) as well as clinical and patients' perspectives. Our Hub approach will allow us to develop novel statistical and mathematical methodologies of relevance to our clinical and industrial partners, informed by relevant patient groups. Building this new generation of quantitative models requires that we advance our mathematical understanding of the effective network interaction and emergent patterns of health and disease. Clinical translation of mathematical and statistical advances necessitates that we further develop robust uncertainty quantification methodology for novel therapy, treatment or intervention prediction and evaluation.
NHS long-term planning aspires to deliver healthcare that is more personalised and patient centred, more focused on prevention, and more likely to be delivered in the community, out of hospital. Our Hub will contribute to this through developing mathematical and statistical tools needed to inform clinical decision making on a patient-by-patient basis. The basis of this approach is quantitative patient-specific mathematical models, the parameters of which are determined directly from individual patient's data.
As an example of this, our recent research in the field of mental health has revealed that movement signatures could be used to distinguish between healthy subjects and patients with schizophrenia. This hypothesis was tested in a cohort of people with schizophrenia and we developed a quantitative analysis pipe line allowing for classification of individuals as healthy or patients. The features used for classification involving data-driven models of individual movement properties as well as measures of coordination with a virtual partner were proposed as a novel biomarker of social phobias. To validate this in an NHS setting, we have recently carried out a feasibility study in collaboration with the early intervention for psychosis teams in Devon Partnership Mental Health Trust. The success of this study could significantly advance the early detection of psychosis by enabling diagnosis using novel markers that are easily measured and analysed and improve accuracy of diagnosis.
Indeed, personalised quantitative models hold the promise for transforming prognosis, diagnosis and treatment of a wide range of clinical conditions. For example, in diabetes where a range of treatment options exist, identifying the optimal medication, and the pattern of its delivery, based upon the profile of the individual will enable us to maximise efficacy, whilst minimising unwanted side effects.
Planned Impact
The Hub will serve as a focal point that brings together a wide-range of end users with the most appropriate for their needs academic expertise available at the University of Exeter in order to deliver our impact strategy. We will engage directly with clinical partners, the wider research community and industry, as well as outreach to patient and the wider public, and via capacity building on the interface of mathematics and healthcare. The activities in WP3 will in particular provide mechanisms for user engagement driven by user needs and priorities that align with the Hub Research Themes.
* NHS: The Hub will create impact for the NHS in terms improved delivery of services that is of interest to health sector managers and policy makers. Quantitative Modelling (QM) in Healthcare involving dynamic models of complex disease along with uncertainty quantification for personalised prognosis and diagnosis could result in significant cost savings to the NHS. The novelty of the Hub is that it endeavours to open new avenues of application of QM in healthcare for much wider range of problems and applications.
* Clinicians: The Hub will to create impact for clinicians by collaborative development of tools that use of quantitative models for personalising diagnosis and predicting treatment responses or outcomes. Multiple health conditions and healthcare providers could benefit from this approach, via applying cutting edge research in a clinical setting that may lead to earlier, more cost effective and more reliable diagnosis. The Hub will promote this through its network of basic researchers and clinical partners through via WP3. For example, researchers at Exeter and clinicians from RD&E are interested in quantifying the link between personal interventions and ongoing metabolic (e.g. microbiomes and endocrine function) health based on monitoring key bio indicators such as lipids or cholesterol.
* Patients: The Hub aims to develop quantitative tools for health management at personalised level. We will pursue active engagement with patients' groups such as the Lived Experience Group at the Mood Disorder Centre. Specifically we will work with patient representatives to develop appropriate public involvement and engagement activities by providing a fresh perspective and encourage researchers to think about the societal problems their research is addressing; commenting on language used in public facing communications; helping prepare for public presentations or outreach events.
* Industry: There is a real potential to incorporate quantitative models including uncertainty quantification into both new and existing healthcare technologies, i.e. into technology and tools for areas such as mental health management. There is further potential for the quantitative models and associated uncertainty quantification tools developed within the Hub to deliver precision medicine technologies for metabolic health and novel antimicrobial therapies.
* Public outreach: Healthcare is an issue that affects all of us at some time as patients or carers and unsurprisingly there is a high level of public interest and newsworthiness of new developments that may revolutionise aspects of healthcare. What is less familiar is the role of mathematics in this, and the Hub will provide a forum to educate on aspects of this.
* Impact via research team training: The Hub will support the training of two postdoctoral researchers and at least 4 PhD students through joint University and industry support. This will include both generic and specific training at the core of mathematics for healthcare. In the longer term this approach will increase the number of highly trained researchers working on the interface between mathematics and healthcare, and so build capacity to ensure that an increasingly data-rich area of healthcare science will pull through to impacts.
* NHS: The Hub will create impact for the NHS in terms improved delivery of services that is of interest to health sector managers and policy makers. Quantitative Modelling (QM) in Healthcare involving dynamic models of complex disease along with uncertainty quantification for personalised prognosis and diagnosis could result in significant cost savings to the NHS. The novelty of the Hub is that it endeavours to open new avenues of application of QM in healthcare for much wider range of problems and applications.
* Clinicians: The Hub will to create impact for clinicians by collaborative development of tools that use of quantitative models for personalising diagnosis and predicting treatment responses or outcomes. Multiple health conditions and healthcare providers could benefit from this approach, via applying cutting edge research in a clinical setting that may lead to earlier, more cost effective and more reliable diagnosis. The Hub will promote this through its network of basic researchers and clinical partners through via WP3. For example, researchers at Exeter and clinicians from RD&E are interested in quantifying the link between personal interventions and ongoing metabolic (e.g. microbiomes and endocrine function) health based on monitoring key bio indicators such as lipids or cholesterol.
* Patients: The Hub aims to develop quantitative tools for health management at personalised level. We will pursue active engagement with patients' groups such as the Lived Experience Group at the Mood Disorder Centre. Specifically we will work with patient representatives to develop appropriate public involvement and engagement activities by providing a fresh perspective and encourage researchers to think about the societal problems their research is addressing; commenting on language used in public facing communications; helping prepare for public presentations or outreach events.
* Industry: There is a real potential to incorporate quantitative models including uncertainty quantification into both new and existing healthcare technologies, i.e. into technology and tools for areas such as mental health management. There is further potential for the quantitative models and associated uncertainty quantification tools developed within the Hub to deliver precision medicine technologies for metabolic health and novel antimicrobial therapies.
* Public outreach: Healthcare is an issue that affects all of us at some time as patients or carers and unsurprisingly there is a high level of public interest and newsworthiness of new developments that may revolutionise aspects of healthcare. What is less familiar is the role of mathematics in this, and the Hub will provide a forum to educate on aspects of this.
* Impact via research team training: The Hub will support the training of two postdoctoral researchers and at least 4 PhD students through joint University and industry support. This will include both generic and specific training at the core of mathematics for healthcare. In the longer term this approach will increase the number of highly trained researchers working on the interface between mathematics and healthcare, and so build capacity to ensure that an increasingly data-rich area of healthcare science will pull through to impacts.
Organisations
- UNIVERSITY OF EXETER (Lead Research Organisation)
- NANYANG TECHNOLOGICAL UNIVERSITY (Collaboration)
- Royal Devon and Exeter NHS Foundation Trust (Collaboration)
- UNIVERSITY OF EXETER (Collaboration)
- Medicines Discovery Catapult (Collaboration)
- Certus Technology (Collaboration)
- University of Bristol (Collaboration)
- North Bristol NHS Trust (Project Partner)
- University of Sydney (Project Partner)
- Brain in Hand (Project Partner)
- Royal Devon and Exeter NHS Fdn Trust (Project Partner)
- Nanyang Technological University (Project Partner)
- Devon Partnership NHS Trust (Project Partner)
- First Databank Europe Ltd (Project Partner)
- IP Pragmatics (Project Partner)
- Brainbow Limited (Project Partner)
- The Alan Turing Institute (Project Partner)
- Ludger (United Kingdom) (Project Partner)
- SW Academic Health Science Network (Project Partner)
- Taunton & Somerset NHS Foundation Trust (Project Partner)
- Certus Technology (United Kingdom) (Project Partner)
Publications
Abbara A
(2024)
Quantifying the variability in the assessment of reproductive hormone levels.
in Fertility and sterility
Arthur T
(2021)
Visuo-motor attention during object interaction in children with developmental coordination disorder
in Cortex
Ashwin P
(2023)
Quasipotentials for coupled escape problems and the gate-height bifurcation.
in Physical review. E
Ashwin P
(2021)
Physical invariant measures and tipping probabilities for chaotic attractors of asymptotically autonomous systems
in The European Physical Journal Special Topics
Ashwin P
(2021)
Dead zones and phase reduction of coupled oscillators.
in Chaos (Woodbury, N.Y.)
Ashwin P
(2024)
Network attractors and nonlinear dynamics of neural computation
in Current Opinion in Neurobiology
Avitabile D
(2023)
Bump Attractors and Waves in Networks of Leaky Integrate-and-Fire Neurons
in SIAM Review
Bain JM
(2021)
Immune cells fold and damage fungal hyphae.
in Proceedings of the National Academy of Sciences of the United States of America
Baker E
(2022)
Analyzing Stochastic Computer Models: A Review with Opportunities
in Statistical Science
Description | Key findings related to the Hub's Research themes: Theme 1: Uncertainty quantification (UQ) for computational modelling in biomedicine and healthcare. We have developed a framework that allows for quantification of uncertainty in modelling patients trajectories (disease progression) in chronic disease such as Duchenne muscular dystrophy (DMD) and lung diseases (COPD, bronchiectasis). The results from this research are being explored in terms of informing therapy and clinical trials design. Theme 2: Reversibility and Resilience(RR): A Mathematical Approach to Evolving Microbial Communities. A framework for modelling combination therapy for infectious disease is being developed including phage therapy. This has implications for precision medicine in this space. |
Exploitation Route | Clinical decision making, clinical trials secondary analysis and design. |
Sectors | Digital/Communication/Information Technologies (including Software) Healthcare Pharmaceuticals and Medical Biotechnology |
Description | Computer models of biological systems have demonstrated their utility in elucidating complex diseases, potentially aiding clinical decisions ranging from crafting personalised healthcare solutions for patients with debilitating health conditions to conducting in silico clinical trials. However, integrating computer models into clinical settings must be executed in a robust, transparent, and standardized manner, accounting for various sources of uncertainty. Uncertainty Quantification (UQ) is a discipline that revolves around quantifying and addressing uncertainties in mathematical and computer models describing real-world processes, with engineering and physical models being extensively studied in this field. Healthcare and biological systems models present unique challenges distinct from the complex computer models traditionally analysed in UQ. Therefore, quantifying uncertainty in healthcare models presents distinct challenges. Our work has focussed on tackling UQ challenges for mechanistic healthcare models by bringing together applied mathematicians, statisticians, and healthcare modellers and raising awareness of suitable approaches and techniques in this space. |
First Year Of Impact | 2023 |
Sector | Healthcare |
Description | Determining the membrane circadian clock across evolution |
Amount | £545,754 (GBP) |
Funding ID | BB/W000865/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 05/2022 |
End | 08/2025 |
Description | LEAP (Leadership Engagement Acceleration & Partnership) - an EPSRC Digital Health Hub |
Amount | £3,290,617 (GBP) |
Funding ID | EP/X031349/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2023 |
End | 09/2026 |
Description | NetClamp: conducting neural network rhythms with mathematics |
Amount | £201,337 (GBP) |
Funding ID | EP/V048716/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 05/2021 |
End | 06/2024 |
Description | The amygdala, a key upstream regulator of the hypothalamic GnRH pulse generator |
Amount | £391,816 (GBP) |
Funding ID | BB/W005883/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 02/2022 |
End | 01/2025 |
Description | Uncertainty Quantification at the Exascale (EXA-UQ) |
Amount | £1,006,031 (GBP) |
Funding ID | EP/W007886/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 07/2021 |
End | 08/2024 |
Description | Understanding molecular accumulation in single cells via microfluidics and omics |
Amount | £512,141 (GBP) |
Funding ID | BB/V008021/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 11/2021 |
End | 04/2024 |
Title | Additional file 2 of Algorithmic hospital catchment area estimation using label propagation |
Description | Additional file 2 Supplementary data - surge capacity estimates. A curated data set of estimated acute and ITU bed capacity in the NHS and private hospitals at the start of the pandemic, in England, Wales, and Scotland. |
Type Of Material | Database/Collection of data |
Year Produced | 2022 |
Provided To Others? | Yes |
URL | https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Algorithmic_hospital_catch... |
Title | Additional file 2 of Algorithmic hospital catchment area estimation using label propagation |
Description | Additional file 2 Supplementary data - surge capacity estimates. A curated data set of estimated acute and ITU bed capacity in the NHS and private hospitals at the start of the pandemic, in England, Wales, and Scotland. |
Type Of Material | Database/Collection of data |
Year Produced | 2022 |
Provided To Others? | Yes |
URL | https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Algorithmic_hospital_catch... |
Title | The antibiotic dosage of fastest resistance evolution: gene amplifications underpinning the inverted-U (dataset) |
Description | This is the dataset used for the Reding et al. (2021) article "The Antibiotic Dosage of Fastest Resistance Evolution: gene amplifications underpinning the inverted-U" published in Molecular Biology and Evolution. |
Type Of Material | Database/Collection of data |
Year Produced | 2021 |
Provided To Others? | Yes |
Impact | To early to tell |
URL | https://ore.exeter.ac.uk/repository/handle/10871/125077 |
Title | hormoneBayes |
Description | hormoneBayes is a novel open-access Bayesian framework that can be easily applied to reliably analyze serial LH measurements to assess LH pulsatility. The framework utilizes parsimonious models to simulate hypothalamic signals that drive LH dynamics, together with state-of-the-art (sequential) Monte-Carlo methods to infer key parameters and latent hypothalamic dynamics. We show that this method provides estimates for key pulse parameters including inter-pulse interval, secretion and clearance rates and identifies LH pulses in line with the current gold-standard deconvolution method. We show that these parameters can distinguish LH pulsatility in different clinical contexts including in reproductive health and disease in men and women (e.g., healthy men, healthy women before and after menopause, women with HA or PCOS). A further advantage of hormoneBayes is that our mathematical approach provides a quantified estimation of uncertainty. Our framework will complement methods enabling real-time in-vivo hormone monitoring and therefore has the potential to assist translation of personalized, data-driven, clinical care of patients presenting with conditions of reproductive hormone dysfunction. |
Type Of Material | Computer model/algorithm |
Year Produced | 2022 |
Provided To Others? | Yes |
Impact | Too early to say. |
URL | https://git.exeter.ac.uk/mv286/hormonebayes |
Description | Anxiety, PTSD, psychosis modelling |
Organisation | University of Exeter |
Department | Mood Disorders Centre Exeter |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Modelling and analysis of EEG, movement and physiological data |
Collaborator Contribution | Providing data and domain expert knowledge |
Impact | Joint MSc and PhD students supervision, collaboration on EPSRC Impact Acceleration award, involving clinical psychology, data science and modelling |
Start Year | 2019 |
Description | Certus Technolgy |
Organisation | Certus Technology |
Country | United Kingdom |
Sector | Private |
PI Contribution | Modelling patients disease trajectory |
Collaborator Contribution | Data |
Impact | Modelling framework and draft manuscript |
Start Year | 2021 |
Description | LEAP Digital Health Hub |
Organisation | University of Bristol |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Providing support for training as part of the LEAP Digital Health Hub. |
Collaborator Contribution | Offering research funding, the LEAP Digital Health Hub is cultivating a multidisciplinary, entrepreneurial, cross-sector Digital Health community across the South West and South Wales. |
Impact | Early stage, no outputs yet |
Start Year | 2023 |
Description | Medicines Discovery Catapult (MDC) |
Organisation | Medicines Discovery Catapult |
Country | United Kingdom |
Sector | Private |
PI Contribution | Industrial Seed Corn Funding to develop a 'Translational Roadmap' with the Medicines Discovery Catapult The aim of this award is to accelerate the translation of promising medicines discovery research underway at the University of Exeter. This call is being proposed for working jointly with the Medicines Discovery Catapult (MDC), an orgranisation dedicated to accelerating drug discovery in the UK, as part of a new strategic partnership between the two institutions. |
Collaborator Contribution | The MDC's VR&D team has substantial drug discovery expertise, and its members have held external innovation roles in large pharmaceutical organisations. In brief, a translational roadmap could broadly consist of (but is not limited to) the following elements: - Application of industrial rigour to review all data associated with the project - Planning of the most efficient/effective line of site to clinic, plausibly with costs & routes to delivery - Understanding of regulatory considerations - Understanding of the market and therapeutics currently in development - Understanding the suitability of the therapeutic to the patient population in question |
Impact | Joint projects |
Start Year | 2020 |
Description | Microbiomes in respiratory disease |
Organisation | Nanyang Technological University |
Country | Singapore |
Sector | Academic/University |
PI Contribution | Developing integrative macrobiotics framework for respiratory disease stratification and AMR |
Collaborator Contribution | Domain expert knowledge and data |
Impact | A number of publications in high profile and clinical journals, involving modelling, data analytics, bioinformatics and clinical expertise |
Start Year | 2020 |
Description | Royal Devon University Healthcare NHS Foundation Trust |
Organisation | Royal Devon and Exeter NHS Foundation Trust |
Country | United Kingdom |
Sector | Public |
PI Contribution | Prof Krasimira Tsaneva-Atanasova is a Co-lead on the AI and Data Science theme as part of the NIHR HealthTech Research Centre on "Diagnostics, rehabilitation and frailty" |
Collaborator Contribution | Data provision and domain (clinical) expertise |
Impact | Early stages, not applicable |
Start Year | 2024 |
Title | Dynamic Clamp Controller |
Description | Dynamic Clamp Controller is a lightweight GUI for uploading parameters to the excellent Arduino and Teensy-based dynamic clamp (https://www.eneuro.org/content/4/5/ENEURO.0250-17.2017). |
Type Of Technology | Software |
Year Produced | 2019 |
Open Source License? | Yes |
Impact | Too early to say |
URL | https://github.com/kyle-wedgwood/DynamicClampController |
Title | hormoneBayes |
Description | hormoneBayes is a novel open-access Bayesian framework that can be easily applied to reliably analyze serial LH measurements to assess LH pulsatility. The framework utilizes parsimonious models to simulate hypothalamic signals that drive LH dynamics, together with state-of-the-art (sequential) Monte-Carlo methods to infer key parameters and latent hypothalamic dynamics. We show that this method provides estimates for key pulse parameters including inter-pulse interval, secretion and clearance rates and identifies LH pulses in line with the current gold-standard deconvolution method. We show that these parameters can distinguish LH pulsatility in different clinical contexts including in reproductive health and disease in men and women (e.g., healthy men, healthy women before and after menopause, women with HA or PCOS). A further advantage of hormoneBayes is that our mathematical approach provides a quantified estimation of uncertainty. Our framework will complement methods enabling real-time in-vivo hormone monitoring and therefore has the potential to assist translation of personalized, data-driven, clinical care of patients presenting with conditions of reproductive hormone dysfunction. |
Type Of Technology | Software |
Year Produced | 2022 |
Open Source License? | Yes |
Impact | Too early to say. |
URL | https://git.exeter.ac.uk/mv286/hormonebayes |
Description | Exeter Summit - Building Better Together, interdisciplinary Q&A panel session on Planetary Health and the recovery from COVID-19 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Schools |
Results and Impact | Exeter Summit - Building Better Together, interdisciplinary Q&A panel session on Planetary Health and the recovery from COVID-19 |
Year(s) Of Engagement Activity | 2021 |
Description | From Enigma to the Programming of Life: Alan Turing's achievements explored in a discussion between Dr Kyle Wedgwood and Sir Dermot Turing. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | This public lecture, which is hosted by the EPSRC Hub for Quantitative Modelling in Healthcare, is intended to provide a platform for people to separate truth from fiction in the story of Alan Turing's scientific accomplishments. Guest speaker, Sir Dermot Turing will be joined by Dr Kyle Wedgwood (lecturer in the Living Systems Institute) to discuss and explore the scientific achievements of Alan Turing across his career. Starting from the efforts to "break" the Enigma machine, Dermot will decipher the real story of Alan Turing's work. Over the course of the evening, Dermot and Kyle will reflect on the impact of Alan Turing's early machines on the development of modern computers, and later, on his contribution to answering fundamental questions about life and the natural world. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.eventbrite.co.uk/e/public-lecture-alan-turing-coding-for-life-tickets-254524237847 |
Description | Fungicast podcast. Neil Gow joins Sarah Campbell to explore the potency, power and potential of fungi with Merlin Sheldrake |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Fungicast podcast. Neil Gow joins Sarah Campbell to explore the potency, power and potential of fungi with Merlin Sheldrake |
Year(s) Of Engagement Activity | 2021 |
URL | https://soundcloud.com/user-621263983/fungicast-episode-1-with-merlin-sheldrake-and-neil-gow |
Description | Futures 2021 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | MakeTank, Paris Street, Exeter by Kyle Wedgwood |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.maketank.org.uk |
Description | How was it done? Breaking the Enigma cipher - maths, not magic with Dermot Turing. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Undergraduate students |
Results and Impact | The Enigma machine cipher was famously broken at Bletchley Park, but for many years GCHQ did not want anyone to know how it was actually done. Beginning with the Enigma machine itself, and its illusory security features, this presentation travels across the different attacks on Enigma from the earliest pre-war attempts to the later sophisticated machine decryption methods. These attacks drew on group theory and the post-Hilbert ideas of incomplete logical systems as well as more traditional cryptanalytical approaches based on language structure. Once the theory was established, creating a fast, workable system for finding Enigma keys required an engineering solution, using binary logic to eliminate wrong settings - a radically new approach leading to the ascendancy of digital computing. Dermot Turing is the acclaimed author of Prof, a biography of his famous uncle, The Story of Computing, and most recently X, Y and Z - the real story of how Enigma was broken. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.exeter.ac.uk/news/events/details/index.php?event=11977 |
Description | Killer Fungus talk, British Science Festival |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Killer Fungus talk, British Science Festival by Neil Gow |
Year(s) Of Engagement Activity | 2021 |
URL | https://britishsciencefestival.seetickets.com/content/ticket-options |
Description | Lorentz Center workshop |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Uncertainty Quantification for Healthcare and Biological Systems Monday 17 till Friday 21 April 2023 Lorentz Center@Snellius The Netherlands Computer models of biological systems have proven to be useful in underpinning complex diseases with the potential to support clinical decisions from designing the personalised healthcare solutions for patients with deliberating health problems to performing in silico clinical trials. However, incorporating computer models into the clinical settings must be done in a robust, transparent and formalised way with a proper consideration of the various sources of uncertainty. Uncertainty Quantification is a field that focuses around quantifying and taking account of uncertainties for mathematical and computer models that describe real-world processes with engineering and physical models being well represented in the field. Healthcare and biological systems models differ significantly from the complex computer models traditionally considered in UQ, and therefore quantifying the uncertainty in healthcare models can pose very different challenges. The aim of this workshop is to identify UQ challenges for mechanistic healthcare models by bringing applied mathematicians, statisticians and healthcare modelers together. |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.lorentzcenter.nl/uncertainty-quantification-for-healthcare-and-biological-systems.html |
Description | Mathematical Modelling meets Medical Mycology |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Study participants or study members |
Results and Impact | Mathematical Modelling meets Medical Mycology engagement event organised by one of the Hub's fellows - Nicolás Verschueren van Rees. The event took place on 11 November 2022 in Reed Hall, University of Exeter, UK |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.exeter.ac.uk/news/events/details/index.php?event=12433 |
Description | Mathematics in Life Sciences workshop: New developments in pattern formation in biological systems, University of Exeter, 14-15th June 2022. |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Study participants or study members |
Results and Impact | The meeting will focus on "New developments in pattern formation in biological systems" and will take place on the 14-15th June 2022 from 13:30 (14th June) to 14:00pm (15th June) in the Newman Red Lecture Theatre in the Peter Chalk Centre, at the University of Exeter (Streatham Campus). |
Year(s) Of Engagement Activity | 2022 |
URL | https://mils.ghost.io/programme-mils-meeting-on-pattern-formation/ |
Description | MiLS meeting on "Linking Mathematics, Experiments and Data" 8th-9th March 2023, University of Exeter |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Study participants or study members |
Results and Impact | The meeting will focus on "Linking mathematics, experiments and data" and will take place on the 8-9th March 2023 from 11:30 (8th March) to 13:30pm (9th March) in the Harrison Building at the University of Exeter (Streatham Campus). |
Year(s) Of Engagement Activity | 2023 |
URL | https://mils.ghost.io/hybrid/ |
Description | School visit |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Schools |
Results and Impact | Title: "Mathematical models of hormonal rhythms" seminar by Dr Margaritis Voliotis Date: 04/03/2022 Venue: South Gloucester and Strout College (SGS), STEM Seminar series |
Year(s) Of Engagement Activity | 2022 |
Description | Screening of 'Our Body is a Planet' followed by discussion between artist and Neil Gow |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Screening of 'Our Body is a Planet' followed by discussion between artist and Neil Gow in Exeter Phoenix |
Year(s) Of Engagement Activity | 2022 |
URL | https://exeterphoenix.org.uk/events/our-body-is-a-plant/ |
Description | Soundart Radio series "Everybody Counts", 24th July 2023 |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Soundart Radio series "Everybody Counts", 24th July 2023 |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.mixcloud.com/Soundart_Radio/everybody-counts-edition-04-240723/ |
Description | THE FUTURE OF AI |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | THE FUTURE OF AI AI is at a crucial point: in this event discover its radiant possibilities as well as the possible changes to all our lives. A world leading panel of experts from business, finance, media and academia discuss the eye-opening scenarios of our future. There is a particular focus on how AI is used to make models for our decisions, regulate our systems, and reduce the impact of uncertainty to solve real-world problems Which areas of our lives will have the most rapid changes? What does this tell us about what it means to be human? |
Year(s) Of Engagement Activity | 2022 |
URL | https://exeterphoenix.org.uk/events/the-future-of-ai/ |
Description | Talk at Chumleigh college on research in mathematics, 28th February 2023. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Talk at Chumleigh college on research in mathematics, 28th February 2023. |
Year(s) Of Engagement Activity | 2023 |